Emergency Department Evaluation and Management of Stroke: Acute Assessment, Stroke Teams and Care Pathways

Neurologic Clinics

Volumn 26, Issue 4, 2008, Pages 923-942

  Gorelick, Alissa R ^a   Gorelick, Philip B ^a   Sloan, Edward P ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTIHYPERTENSIVE AGENT; ETOMIDATE; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; HEPARIN; LABETALOL; MIDAZOLAM; NICARDIPINE; NITROPRUSSIDE SODIUM; PLACEBO; PROPOFOL; SARUPLASE; THIOPENTAL; WARFARIN;

BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; ELECTROCARDIOGRAM; EMERGENCY HEALTH SERVICE; EMERGENCY PHYSICIAN; ENDOTRACHEAL INTUBATION; FIBRINOLYTIC THERAPY; HEALTH CARE PERSONNEL; HEART ATRIUM FIBRILLATION; HUMAN; HYPERBARIC OXYGEN; HYPERGLYCEMIA; HYPERTENSION; HYPERTHERMIA; HYPOTENSION; MAGNETIC RESONANCE ANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN THERAPY; PATIENT CARE; PERCUTANEOUS THROMBECTOMY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; STROKE; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; THORAX RADIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; VENOUS THROMBOEMBOLISM;

EMERGENCY SERVICE, HOSPITAL; HUMANS; PATIENT CARE TEAM; STROKE; TIME FACTORS;

EID: 56249110590     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2008.05.008     Document Type: Review

References (55)

1. American Heart Association. Heart Disease and Stroke Statistics: 2008 update. Available at: www.americanheart.org/statistics. Accessed July 7, 2008.
2. Kleindorfer D., Lindsell C.J., Brass L., et al. National US estimates of recombinant tissue plasminogen activator use. ICD-9 codes substantially underestimate. Stroke 39 (2008) 924-928
3. Marler J.R., and Goldstein L.B. Stroke-tPA and the clinic. Science 301 (2003) 1677-1679
4. Morris D.L., Rosamond W., Madden K., et al. Prehospital and emergency department delays after acute stroke. The Genentech stroke prevention survey. Stroke 31 (2000) 2528-2590
5. Schroeder E.B., Rosamond W.D., Morris D.L., et al. Determinants of use of emergency medical services in a population with stroke symptoms. The second delay in accessing stroke healthcare [DASH II study]. Stroke 31 (2000) 2591-2596
6. Gordon D.L. The Mississippi Stroke Education Consortium: a state-based template to promote stroke awareness, prevention, and emergency treatment. Neuroepidemiology 19 (2000) 1-12
7. Hazinski M.F. Demystifying recognition and management of stroke. Current Emergency Cardiac Care 7 (1996) 8-9
8. Pepe P.E., Zachariah B.S., Sayre M.R., et al. Ensuring the chain of recovery for stroke in your community. Acad Emerg Med 5 (1998) 89-95
9. Kidwell C.S., and Saver J.L. Rapid clinical evaluation. In: Kasner S.E., and Gorelick P.B. (Eds). Prevention and treatment of ischemic stroke (2004), Butterworth/Heinemann, Philadelphia 211-235
10. Acker J.E., Pancioli A.M., Crocco T.J., et al. Implementation strategies for emergency medical services within stroke systems of care. A policy statement from the American Heart Association/American Stroke Association expert panel on emergency medical services systems and the Stroke Council. Stroke 116 (2007) 3097-3115
11. Kidwell C.S., Saver J.L., Eckstein M., et al. Improving paramedic recognition of stroke in the field: a Los Angeles prehospital stroke screen (LAPSS). Stroke 29 (1998) 313 [abstract]
12. Cohen S.N. Management of ischemic stroke (2000), McGraw-Hill, New York
13. Kothari R., Hall K., Brott T., et al. Early stroke recognition: developing an out-of-hospital NIH stroke scale. Acad Emerg Med 4 (1997) 986-990
14. Kothari R.U., Pancioli A., Liu T., et al. Cincinnati prehospital stroke scale: validity and reproducibility. Ann Emerg Med 33 4 (1999 Apr) 373-378
15. Harbison J., Houssain O., Jenkinson D., et al. Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face, arm, speech test. Stroke 34 (2003) 71-76
16. Chalela J.A., Kasner S.E., Jauch E.D., et al. Safety of air medical transportation after tissue plasminogen activator administration in acute ischemic stroke. Stroke 30 (1999) 2366-2368
17. Hess D.C., Wang S., Gross H., et al. Telestroke: extending stroke expertise into underserved areas. Lancet Neurol 5 (2006) 275-278
18. Saver J.L., Kidwell C.S., Leary M.C., et al. Results of the field administration of stroke treatment-magnesium (fast-mag) pilot trial: a study of prehospital neuroprotective therapy. Stroke 33 (2002) 363-364
19. Alberts M.A., Hademenos G., Latchaw R.L., et al. Recommendations for the establishment of primary stroke centers. JAMA 283 (2000) 3102-3109
20. Bock BF. Response system for patients presenting with acute stroke. In: Marler JR, Jones PM, Emr M, editors. Proceeding of a National Symposium on rapid identification and treatment of acute stroke: 1997. Bethesda (MD): National Institute of Neurological Disorders and Stroke, National Institutes of Health; 1997.
21. Albers G.W., Amarenco P., Easton J.D., et al. Antothrombotic and thrombolytic therapy for ischemic stroke: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126 (2004) 483S-512S
22. Gorelick P.B., and Weber M.A. Handbook of stroke prevention and treatment (2007), Current Medicine Group, London
23. Morgenstern L., Luna-Gonzales H., Huber J.C., et al. Worst headache and subarachnoid hemorrhage: prospective, modern computed tomography and spinal fluid analysis. Ann Emerg Med 32 (1998) 297
24. Tarr R.W., Hecht S.T., and Horton J.A. Nontraumatic intracranial hemorrhage. In: LRE (Ed). Magnetic resononance and computerized tomography imaging of the head, neck, and spine (1991), Mosby Year Book, St. Louis (MO) 267-299
25. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: tissue plasminogen activator for acute ischemic stroke. NEJM 333 (1995) 1581-1588
26. Wardlaw J.M., Farrall A.J., and Perry D. Factors influencing the detection of early CT signs of cerebral ischemia. Stroke 38 (2007) 1250-1256
27. Khaja A.M., and Grotta J. Established treatments for acute ischemic stroke. Lancet 369 (2007) 319-330
28. Johnston K., and Haley E.C. Emergency imaging of the acute stroke patient. J Neuroimaging 7 (1997) 111-117
29. Chalela J.A., Kidwell C.S., Nentwich L.M., et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 369 (2007) 203-298
30. Adams H.P., del Zoppo G., Alberts M., et al. Guidelines for the early management of adults with ischemic stroke. Stroke 38 (2007) 1655-1711
31. Strandgaard S. Autoregualtion of cerebral blood flow in hypertensive patients: the modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension. Circulation 53 (1976) 720-727
32. Broderick J., Connolly S., Feldmann E., et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults. 2007 update. Stroke 38 (2007) 2006-2007
33. Gray C.S., Hildreth A., Sandercock P.A., et al. Glucose-potassium-insulin infusions in management of post-stroke hyperglycemia: the UK glucose insulin trial (GIST-UK). Lancet Neurol 6 (2007) 397-406
34. Ginsberg M., and Busto R. Combating hyperthermia in acute stroke: a significant clinical concern. Stroke 29 (1998) 529-534
35. Demaerschalk B.M. Thrombolytic therapy for acute ischemic stroke. The likelihood of being helped versus harmed. Stroke 38 (2007) 2215-2216
36. Wahlgren N., Ahmed N., Davalos A., et al. Thrombolysis with alteplase for acute ischemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): an observational study. Lancet 369 (2007) 275-282
37. Al-Senani F.M., and Grotta J.C. Thrombolytic therapies. In: Kasner S.E., and Gorelick P.B. (Eds). Prevention and treatment of ischemic stroke (2004), Butterworth Heinemann, Philadelphia 267-281
38. Barber P.A., Zhang J., Demchuk A.M., et al. Why are stroke patients excluded from TPA therapy?: an analysis of patient eligibility. Neurology 56 (2001) 1015-1020
39. Baumann C.R., Baumgartner R.W., Gandjour J., et al. Good outcomes in ischemic stroke patients treated with intravenous thrombolysis despite regressing neurological symptoms. Stroke 37 (2006) 1332-1333
40. O'Connor R.E., McGraw P., and Edelsohn L. Thrombolytic therapy for acute ischemic stroke: why the majority of patients remain ineligible for treatment. Ann Emerg Med 33 (1999) 9-14
41. Cocho D., Belvis R., Marti-Fabregas J., et al. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurology 64 (2005) 719-720
42. Furlan A., Higashita R.T., Wechsler L., et al. Intra-arterial pro-urokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 282 (1999) 2003-2011
43. Mandava P., and Kent T.A. Intra-arterial therapies for acute ischemic stroke. Neurology 68 (2007) 2132-2139
44. Smith W.S., Sung G., Starkman S., et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36 (2005) 1432-1440
45. McDougall C, Clark W, Mayer T, et al. The Penumbra Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in acute ischemic stroke. Presented at the International Stroke Conference 2008, Late Breakers Session. New Orleans, LA, February 22, 2008.
46. Coull B.M., Williams L.S., Goldstein L.B., et al. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Stroke 33 (2002) 1934-1942
47. Edlow J.A., Kim S., and Pelletier A.J. National study on emergency department visits for transient ischemic attack, 1992-2001. Acad Emerg Med 13 (2006) 666-672
48. Bos M.J., van Rijn M.J., Witteman J.C., et al. Incidence and prognosis of transient neurological attacks. JAMA 298 24 (2007) 2877-2885
49. Rothwell P.M., Giles M.F., Chandratheva A., et al. Effect of urgent treatment of transient ischemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 370 (2007) 1432-1442
50. Ross M.A., Compton S., Medado P., et al. An emergency department diagnostic protocol for patients with transient ischemic attack: a randomized controlled trial. Ann Emerg Med 50 (2007) 109-119
51. Johnston S.C., Nguyen-Huynh M.N., Schwarz M.E., et al. National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol 60 3 (2006) 301-313
52. Ovbiagele B. The emergency department: first line of defense in preventing secondary stroke. Acad Emerg Med 13 (2006) 215-222
53. Collins R., Armitage J., Parish S., et al., Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 363 (2004) 757-767
54. Sacco R.L., Adams R., Albers G., et al. Guidelines for prevention of stroke in patients with ischemic stroke of transient ischemic attack. Stroke 37 (2006) 577-617
55. Adams RJ, Albers G, Alberts MJ, et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke; 39, in press.